New Market Research Reports
We constantly update the database in order to offer our customers the broadest possible choice of market research reports and meet all their needs. Browse the most recent publications below.
Tea/Export Opportunities in Chile
US$ 299.00
August 2019
46 pages
Maple Sugar and Maple Syrup/Export Opportunities in Latin America
US$ 149.00
September 2019
41 pages
Locks of Base Metal/Export Opportunities in the Pacific Alliance (Mexico, Chile, Colombia & Peru)
US$ 299.00
September 2019
74 pages
Yoghurts and Sour Milk Products in Eastern Europe
US$ 1,325.00
October 2019
62 pages
WestRock in Packaging (World)
US$ 572.00
October 2019
23 pages
Weight Management and Wellbeing in Switzerland
US$ 990.00
October 2019
20 pages
Spotlight on Luxury Travel: The Power of Nature
US$ 1,325.00
October 2019
23 pages
Sports Nutrition in Cameroon
US$ 990.00
October 2019
14 pages
NRT Smoking Cessation Aids in Chile
US$ 990.00
October 2019
13 pages
Consumer Health in Tanzania
US$ 2,100.00
October 2019
58 pages
Consumer Health in Ghana
US$ 2,100.00
October 2019
64 pages
Beer Global Value Shares: Quality Over Quantity?
US$ 1,325.00
October 2019
17 pages
Yellow Fever Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
60 pages
Western Equine Encephalitis Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
40 pages
West Nile Virus Infections Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
50 pages
Ventilator Associated Pneumonia (VAP) Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
80 pages
Vancomycin Resistant Staphylococcus aureus (VRSA) Infections Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
50 pages
Vancomycin Resistant Enterococcus (VRE) faecium Infections Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
70 pages
Typhoid Fever Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
50 pages
Tularemia Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
40 pages
Toxoplasmosis Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
40 pages
Tinea pedis (Athlete Foot) Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
40 pages
Tetanus Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
70 pages
Streptococcus pyogenes Infections Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
50 pages
Smallpox Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
50 pages
Severe Acute Respiratory Syndrome (SARS) Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
70 pages
Schistosomiasis Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
40 pages
Rotavirus Infections Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
50 pages
Rhinovirus Infections Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
50 pages
Rabies Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
60 pages
Q Fever Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
20 pages
Pyelonephritis Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
60 pages
Pseudomonas aeruginosa Pneumonia Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
40 pages
Progressive Multifocal Leukoencephalopathy Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
40 pages
Poliomyelitis (Polio) Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
70 pages
Pertussis (Whooping Cough) Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
70 pages
Osteomyelitis Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
30 pages
Neisseria meningitidis Infections Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
70 pages
Mumps Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
40 pages
Middle East Respiratory Syndrome (MERS) Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
70 pages
Methicillin-Susceptible Staphylococcus aureus (MSSA) Infections Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
40 pages
Meningitis Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
30 pages
Measles Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
40 pages
Marburgvirus Infections (Marburg Hemorrhagic Fever) Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
60 pages
Lymphatic Filariasis (Elephantiasis) Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
30 pages
Lyme Disease Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
50 pages
Leishmaniasis (Kala-Azar) Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
100 pages
Lassa Fever (Lassa Hemorrhagic Fever) Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
50 pages
Klebsiella pneumoniae Infections Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
100 pages
Japanese Encephalitis Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
40 pages
Influenzavirus B Infections Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
100 pages
Influenza A Virus, H7N9 Subtype Infections Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
60 pages
Influenza A Virus, H5N1 Subtype Infections Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
130 pages
Influenza A Virus, H3N2 Subtype Infections Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
120 pages
Impetigo Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
30 pages
Human Parainfluenza Virus Type 3 Infections Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
40 pages
Hospital Acquired Pneumonia (HAP) Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
80 pages
Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
40 pages
Herpes Zoster (Shingles) Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
50 pages
Herpes Labialis (Oral Herpes) Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
50 pages
Hepatitis E Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
30 pages
Hepatitis D Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
50 pages
Hepatitis A Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
30 pages
Hand, Foot and Mouth Disease Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
40 pages
Haemophilus influenzae Type B Infections Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
60 pages
Gonorrhea Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
50 pages
Genital Herpes Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
70 pages
Epstein–Barr Virus (HHV-4) Infections Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
90 pages
Diphtheria Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
70 pages
Dengue Fever Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
150 pages
Cryptosporidiosis Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
40 pages
Cryptococcosis Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
40 pages
Community Acquired Pneumonia Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
70 pages
Coccidioidomycosis Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
40 pages
Cholera Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
50 pages
Chlamydia Infections Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
50 pages
Chikungunya Fever Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
80 pages
Chagas Disease (American Trypanosomiasis) Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
70 pages
Candidiasis Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
130 pages
Burkholderia pseudomallei Infections (Melioidosis) Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
50 pages
Botulism Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
40 pages
Bacterial Vaginosis Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
50 pages
Bacillary Dysentery (Shigellosis) Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
40 pages
Aspergillosis Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
80 pages
Anthrax Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
70 pages
African Trypanosomiasis Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
40 pages
Acinetobacter Infections Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs
US$ 1,699.00
October 2019
150 pages
Next Generation Sequencing Services Market by Service Type (Targeted Sequencing, Exome, RNA-Seq, ChIP Sequencing), Technology (Sequencing by Synthesis, Nanopore, SMRT), Application (Clinical Diagnosis, Biomarker Discovery), and End User - Global Forecast to 2025
US$ 4,375.00
October 2019
193 pages
Electric and Electronic Fuses Market by Type (Electric and Electronic), by Fuse Type (Power Fuse and Fuse Link, Distribution Cutouts, Cartridge and Plug Fuse), Voltage (Low, Medium), and Application (Utilities, Industrial, Residential, Commercial) - Global Forecast to 2025
US$ 4,175.00
October 2019
155 pages
Collagen Market by Product (Gelatine and Collagen Peptide), Source (Porcine, Bovine, Marine, Chicken, Sheep), Application (Food and Beverages, Pharmaceuticals, Nutraceuticals, Cosmetics, Healthcare), and Geography – Global Forecast to 2025
US$ 4,175.00
October 2019
206 pages
American Whiskey Market by Type (Bourbon, Tennessee, Rye Whiskey), Geography (U.S., Canada, Mexico, U.K., Germany, France, Spain, Russia, Poland, Italy, Austria, Switzerland, Australia, Japan, China, India, Brazil, Argentina, Chile) - Forecast to 2025
US$ 4,175.00
October 2019
120 pages
Translucent Concrete Market by Raw Material Type (Concrete, Optical Elements), Application (Facade & Wall Cladding, Flooring), End-use Industry (Construction & Infrastructure), and Region (NA, EU, APAC, MEA, LA) - Global Forecast to 2024
US$ 5,650.00
October 2019
129 pages
Osteoarthritis Therapeutics Market by Anatomy (Knee, Hip), Drug Type (NSAIDs, Corticosteroids), Route of Administration (Parenteral, Topical), Distribution Channel (Hospital Pharmacies), Purchasing Pattern (Prescription Drugs) - Global Forecast to 2024
US$ 5,650.00
October 2019
148 pages
Electronic Drug Delivery Systems Market by Type (Electronic Wearable Infusion Pump, Autoinjectors, Injection Pens, Electronic Inhalers), Indication (Diabetes, Multiple Sclerosis, Cardiovascular Disease, Asthma & COPD) - Global Forecast to 2024
US$ 5,650.00
October 2019
125 pages
Western Blotting: Global Markets
US$ 3,950.00
October 2019
56 pages
Predisposition Biomarkers: Technologies and Global Markets
US$ 3,950.00
October 2019
72 pages
Over-the-Counter (OTC) Drugs and Dietary Supplements: Opportunities for Consumer Goods Distributors
US$ 3,950.00
October 2019
41 pages
Lead-Free Piezoelectric Ceramics: Technologies and Global Opportunities
US$ 5,500.00
October 2019
153 pages
Green Diesel: Further Developments in the Alternative Fuel Space
US$ 2,500.00
October 2019
19 pages
Global Cryostat Microtome Equipment Market
US$ 5,500.00
October 2019
103 pages